Novel probiotic-fermented milk with angiotensin I-converting enzyme inhibitory peptides produced by Bifidobacterium bifidum MF 20/5

International Journal of Food Microbiology

Volumn 167, Issue 2, 2013, Pages 131-137

  Gonzalez Gonzalez, Cid ^a   Gibson, Trevor ^a   Jauregi, Paula ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

ACE; Bifidobacteria; Bioactive peptides; Fermented milk; Probiotics

Indexed keywords

AMINO ACID; ANTIOXIDANT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MILK PROTEIN; PEPTIDE; PROBIOTIC AGENT;

ARTICLE; BIFIDOBACTERIUM BIFIDUM; COMPUTER MODEL; CONTROLLED STUDY; ENZYME INHIBITION; FERMENTED PRODUCT; HYDROLYSIS; LACTOBACILLUS HELVETICUS; MILK; NONHUMAN; PH;

BIFIDOBACTERIUM BIFIDUM; LACTOBACILLUS HELVETICUS;

ACE; BIFIDOBACTERIA; BIOACTIVE PEPTIDES; FERMENTED MILK; PROBIOTICS;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BIFIDOBACTERIUM; CHROMATOGRAPHY, LIQUID; FERMENTATION; HYDROGEN-ION CONCENTRATION; HYDROLYSIS; LACTOBACILLUS HELVETICUS; MILK; OLIGOPEPTIDES; PROBIOTICS; TANDEM MASS SPECTROMETRY;

EID: 84885733173     PISSN: 01681605     EISSN: 18793460     Source Type: Journal    
DOI: 10.1016/j.ijfoodmicro.2013.09.002     Document Type: Article

References (44)

1. Bobe G., Beitz D.C., Freeman A.E., Lindberg G.L. Separation and quantification of bovine milk proteins by reversed-phase high-performance liquid chromatography. J. Agric. Food Chem. 1998, 46(2):458-463.
2. Chen G.-W., Tsai J.-S., Sun Pan B. Purification of angiotensin I-converting enzyme inhibitory peptides and antihypertensive effect of milk produced by protease-facilitated lactic fermentation. Int. Dairy J. 2007, 17(6):641-647.
3. Church F.C., Swaisgood H.E., Porter D.H., Catignani G.L. Spectrophotometric assay using o-phthaldialdehyde for determination of proteolysis in milk and isolated milk proteins. J. Dairy Sci. 1983, 66(6):1219-1227.
4. Cushman D.W., Cheung H.S. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem. Pharmacol. 1971, 20(7):1637-1648.
5. de Vries W., Gerbrandy S.J., Stouthamer A.H. Carbohydrate metabolism in Bifidobacterium bifidum. Biochem. Biophys. Acta 1967, 136(3):415-425.
6. Donkor O.N., Henriksson A., Singh T.K., Vasiljevic T., Shah N.P. ACE-inhibitory activity of probiotic yoghurt. Int. Dairy J. 2007, 17(11):1321-1331.
7. Elmore J.S., Koutsidis G., Dodson A.T., Mottram D.S., Wedzicha B.L. Measurement of acrylamide and its precursors in potato, wheat, and rye model systems. J. Agric. Food Chem. 2005, 53(4):1286-1293.
8. FitzGerald R.J., Meisel H. Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme. Br. J. Nutr. 2000, 84(Suppl. 1):S33-S37.
9. FitzGerald R.J., Murray B.A., Walsh D.J. Hypotensive peptides from milk proteins. J. Nutr. 2004, 134(4):980S-988S.
10. Flambard B. Peptides with anti-hypertensive properties, world patent. WO/2003/082019 2003.
11. Fox P.F., Stepaniak L. Enzymes in cheese technology. Int. Dairy J. 1993, 3(4â€"6):509-530.
12. Gasteiger E., Gattiker A., Hoogland C., Ivanyi I., Appel R.D., Bairoch A. ExPASy: the proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res. 2003, 31(13):3784-3788.
13. Gobbetti M., Minervini F., Rizzello C.G. Angiotensin I-converting-enzyme-inhibitory and antimicrobial bioactive peptides. Int. J. Dairy Technol. 2004, 57(2-3):173-188.
14. Gonzalez-Gonzalez C.R., Tuohy K.M., Jauregi P. Production of angiotensin-I-converting enzyme (ACE) inhibitory activity in milk fermented with probiotic strains: effects of calcium, pH and peptides on the ACE-inhibitory activity. Int. Dairy J. 2011, 21(9):615-622.
15. Hata Y., Yamamoto M., Ohni M., Nakajima K., Nakamura Y., Takano T. A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Am. J. Clin. Nutr. 1996, 64(5):767-771.
16. Hernandez-Ledesma B., del Mar Contreras M., Recio I. Antihypertensive peptides: production, bioavailability and incorporation into foods. Adv. Colloid Interf. Sci. 2011, 165(1):23-35.
17. Husek P.C. Method of Preparing Sample for Amino Acid Analysis and Kit for Analyzing the Same 2000, Phenomenex Inc, US.
18. Inoue K., Shirai T., Ochiai H., Kasao M., Hayakawa K., Kimura M., Sansawa H. Blood-pressure-lowering effect of a novel fermented milk containing gamma-aminobutyric acid (GABA) in mild hypertensives. Eur. J. Clin. Nutr. 2003, 57(3):490-495.
19. Jauhiainen T., Ronnback M., Vapaatalo H., Wuolle K., Kautiainen H., Groop P.H., Korpela R. Long-term intervention with Lactobacillus helveticus fermented milk reduces augmentation index in hypertensive subjects. Eur. J. Clin. Nutr. 2010, 64:424-431.
20. Keil B. Specificity of Proteolysis 1992, Springer-Verlag.
21. Kilpi E.E.R., Kahala M.M., Steele J.L., Pihlanto A.M., Joutsjoki V.V. Angiotensin I-converting enzyme inhibitory activity in milk fermented by wild-type and peptidase-deletion derivatives of Lactobacillus helveticus CNRZ32. Int. Dairy J. 2007, 17(8):976-984.
22. Kohmura M., Nio N., Kubo K., Minoshima Y., Munekata E., Ariyoshi Y. Inhibition of Angiotensin-converting Enzyme by Synthetic Peptides of Human Beta-casein 1989, Agricultural Chemical Society of Japan, Tokyo, Japan.
23. Kunji E.R., Mierau I., Hagting A., Poolman B., Konings W.N. The proteolytic systems of lactic acid bacteria. Antonie Van Leeuwenhoek 1996, 70(2-4):187-221.
24. Larsen L.B., Benfeldt C., Rasmussen L.K., Petersen T.E. Bovine milk procathepsin D and cathepsin D: coagulation and milk protein degradation. J. Dairy Res. 1996, 63(01):119-130.
25. Leclerc P.-L., Gauthier S.F., Bachelard H., Santure M., Roy D. Antihypertensive activity of casein-enriched milk fermented by Lactobacillus helveticus. Int. Dairy J. 2002, 12(12):995-1004.
26. Matsufuji H., Matsui T., Ohshige S., Kawasaki T., Osajima K., Osajima Y. Antihypertensive effects of angiotensin fragments in SHR. Biosci. Biotechnol. Biochem. 1995, 59(8):1398-1401.
27. Minkiewicz P., Dziuba J., Iwaniak A., Dziuba M., Darewicz M. BIOPEP database and other programs for processing bioactive peptide sequences. J. AOAC Int. 2008, 91(4):965-980.
28. Nakamura Y., Yamamoto N., Sakai K., Okubo A., Yamazaki S., Takano T. Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk. J. Dairy Sci. 1995, 78(4):777-783.
29. Nakano D., Ogura K., Miyakoshi M., Ishii F., Kawanishi H., Kurumazuka D., Kwak C.-j., Ikemura K., Takaoka M., Moriguchi S., Iino T., Kusumoto A., Asami S., Shibata H., Kiso Y., Matsumura Y. Antihypertensive effect of angiotensin I-converting enzyme inhibitory peptides from a sesame protein hydrolysate in spontaneously hypertensive rats. Biosci. Biotechnol. Biochem. 2006, 70(5):1118-1126.
30. Nielsen M.S., Martinussen T., Flambard B., Sørensen K.I., Otte J. Peptide profiles and angiotensin-I-converting enzyme inhibitory activity of fermented milk products: effect of bacterial strain, fermentation pH, and storage time. Int. Dairy J. 2008, 19(3):155-165.
31. Nomura M., Kimoto H., Someya Y., Furukawa S., Suzuki I. Production of γ-aminobutyric acid by cheese starters during cheese ripening. J. Dairy Sci. 1998, 81(6):1486-1491.
32. Otte J., Lenhard T., Flambard B., Sørensen K.I. Influence of fermentation temperature and autolysis on ACE-inhibitory activity and peptide profiles of milk fermented by selected strains of Lactobacillus helveticus and Lactococcus lactis. Int. Dairy J. 2010, 21(4):229-238.
33. Pan D., Guo Y. Optimization of sour milk fermentation for the production of ACE-inhibitory peptides and purification of a novel peptide from whey protein hydrolysate. Int. Dairy J. 2010, 20(7):472-479.
34. Ramchandran L., Shah N.P. Proteolytic profiles and angiotensin-I converting enzyme and alpha-glucosidase inhibitory activities of selected lactic acid bacteria. J. Food Sci. 2008, 73(2):M75-M81.
35. Rival S.G., Fornaroli S., Boeriu C.G., Wichers H.J. Caseins and casein hydrolysates. 1. Lipoxygenase inhibitory properties. J. Agric. Food Chem. 2001, 49(1):287-294.
36. Saito Y., Wanezaki K., Kawato A., Imayasu S. Structure and activity of angiotensin I converting enzyme inhibitory peptides from sake and sake lees. Biosci. Biotechnol. Biochem. 1994, 58(10):1767-1771.
37. Savijoki K., Ingmer H., Varmanen P. Proteolytic systems of lactic acid bacteria. Appl. Microbiol. Biotechnol. 2006, 71(4):394-406.
38. Seppo L., Jauhiainen T., Poussa T., Korpela R. A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. Am. J. Clin. Nutr. 2003, 77(2):326-330.
39. Sousa M.J., Ardö Y., McSweeney P.L.H. Advances in the study of proteolysis during cheese ripening. Int. Dairy J. 2001, 11(4â€"7):327-345.
40. Terashima M., Oe M., Ogura K., Matsumura S. Inhibition strength of short peptides derived from an ACE inhibitory peptide. J. Agric. Food Chem. 2011, 59(20):11234-11237.
41. Torino M.I., Taranto M.P., Sesma F., De Valdez G.F. Heterofermentative pattern and exopolysaccharide production by Lactobacillus helveticus ATCC 15807 in response to environmental pH. J. Appl. Microbiol. 2001, 91(5):846-852.
42. Tuomilehto J., Lindstrom J., Hyyrynen J., Korpela R., Karhunen M.L., Mikkola L., Jauhiainen T., Seppo L., Nissinen A. Effect of ingesting sour milk fermented using Lactobacillus helveticus bacteria producing tripeptides on blood pressure in subjects with mild hypertension. J. Hum. Hypertens. 2004, 18(11):795-802.
43. Vercruysse L., Morel N., Van Camp J., Szust J., Smagghe G. Antihypertensive mechanism of the dipeptide Val-Tyr in rat aorta. Peptides 2008, 29(2):261-267.
44. Wakai T., Yamamoto N. Antihypertensive peptides specific to Lactobacillus helveticus fermented milk. Biotechnology - Molecular Studies and Novel Applications for Improved Quality of Human Life 2012, InTech. R.H. Sammour (Ed.).